Fort Sheridan Advisors »

SPDR S&P Biotech shares owned by Fort Sheridan Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Fort Sheridan Advisors from 13F filings

Historical chart of Fort Sheridan Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Fort Sheridan Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Fort Sheridan Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $493k 4.9k 100.20

More positions owned by Fort Sheridan Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Enterprise Products Partners (EPD)
Cme (CME)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Oneok (OKE)
Blackstone Group Inc Com Cl A (BX)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Abbvie (ABBV)
Meta Platforms Cl A (META)
Intercontinental Exchange (ICE)
Johnson & Johnson (JNJ)

View all positions for Fort Sheridan Advisors

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech